Study to Compare the Efficacy and Safety of Two CC-5013 Dose Regimens in Subjects With Metastatic Malignant Melanoma
- Conditions
- MelanomaNeoplasm Metastasis
- Registration Number
- NCT00055562
- Lead Sponsor
- Celgene Corporation
- Brief Summary
Subjects are randomized to one of two treatment arms. All subjects are screened for eligibility within 28 days prior to randomization. The study consists of a treatment phase and a follow-up phase. Subjects will be treated in repeating 4 week cycles.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 274
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (31)
UPMC Cancer Pavillion
🇺🇸Pittsburgh, Pennsylvania, United States
Princess Margaret Hospital
🇨🇦Toronto, Ontario, Canada
Massachusetts General Hospital
🇺🇸Boston, Massachusetts, United States
MD Anderson Cancer Center
🇺🇸Houston, Texas, United States
Cancer Care Manitoba
🇨🇦Winnipeg, Manitoba, Canada
The Harold Lever Regional Cancer Center
🇺🇸Waterbury, Connecticut, United States
Washington University School of Medicine
🇺🇸St. Louis, Missouri, United States
University of Southern California Norris Cancer Center
🇺🇸Los Angeles, California, United States
Spectrum Health
🇺🇸Grand Rapids, Michigan, United States
University of Arizona Cancer Center
🇺🇸Tucson, Arizona, United States
Carle Clinic
🇺🇸Urbana, Illinois, United States
Mount Sinai Comprehensive Cancer Center
🇺🇸Miami Beach, Florida, United States
Lutheran General
🇺🇸Park Ridge, Illinois, United States
Lakeland Regional Cancer Center
🇺🇸Lakeland, Florida, United States
Outpatient Clinic
🇺🇸Santa Monica, California, United States
Beth Israel Deaconess Medical Ctr
🇺🇸Boston, Massachusetts, United States
Cleveland Clinic Foundation
🇺🇸Cleveland, Ohio, United States
Melanoma Center of St Louis
🇺🇸St. Louis, Missouri, United States
Ellis Fischel Cancer Center
🇺🇸Columbia, Missouri, United States
UCLA
🇺🇸Los Angeles, California, United States
Cross Cancer Institute
🇨🇦Edmonton, Alberta, Canada
L'Hotel Dieu de Quebec
🇨🇦Quebec, Canada
St. Francis Memorial Hospital
🇺🇸San Francisco, California, United States
University of Colorado
🇺🇸Aurora, Colorado, United States
The Linder Clinical Trial Center
🇺🇸Cincinnati, Ohio, United States
Sarah Cannon Cancer Center
🇺🇸Nashville, Tennessee, United States
Penn State Hershey Medical Center
🇺🇸Hershey, Pennsylvania, United States
Biomedical Research Alliance of New York
🇺🇸New York, New York, United States
Memorial Sloan Kettering Cancer Center
🇺🇸New York, New York, United States
Tom Baker Cancer Center
🇨🇦Calgary, Alberta, Canada
Qell Health Sciences Center
🇨🇦Halifax, Nova Scotia, Canada